PLG0206

DRUG2 trials

Sponsors

Peptilogics

Conditions

Joint InfectionProsthetic-joint Infection

Phase 1

Study in Patients Undergoing Debridement, Antibiotics, and Implant Retention (DAIR) for Treatment of a Periprosthetic Joint Infection (PJI) Occurring After Total Knee Arthroplasty (TKA)

CompletedNCT05137314

PeptilogicsJoint Infection

Start: 2022-03-31End: 2024-03-19Updated: 2025-05-21

Phase 2

Evaluation of PLG0206 in Prevention of Recurrent Infection in Patients Undergoing Debridement, Antibiotics, and Implant Retention (DAIR) for Treatment of a Periprosthetic Joint Infection (PJI) Following Knee Arthroplasty

RecruitingNCT07214311

PeptilogicsProsthetic-joint Infection

Start: 2026-02-03End: 2028-09-01Target: 240Updated: 2026-09-18